Kura Oncology Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -73.8% | +8.4% | +35.7% | -16.5% | +5.4% | +14.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +14.8% | +29.0% | +3.8% | +6.6% | +3.4% | +5.5% | +6.7% | +0.0% | +3.4% | +1.4% | -0.9% | +9.3% | -13.7% | +3.0% | -1.9% | -100.0% | – | +1,333.9% | -85.7% | +34.1% | -60.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -73.8% | +8.4% | +14.7% | -1.2% | +1.8% | +16.9% | – | |
| – | +3.5% | +0.2% | +2.5% | +26.4% | +13.7% | +42.5% | -0.8% | +1.6% | +3.6% | -14.1% | +10.2% | +9.6% | +7.4% | -6.6% | +8.9% | +21.2% | +5.6% | +16.0% | +3.7% | +6.1% | -6.3% | -0.2% | +16.0% | +2.9% | -9.2% | +11.1% | +11.9% | +4.1% | +10.9% | +11.5% | +9.5% | +5.0% | +25.3% | +7.1% | +12.2% | +8.2% | -5.2% | +1.3% | -5.2% | – | |
| – | +13.4% | +8.4% | +6.4% | +3.5% | +22.0% | +19.1% | +10.9% | +13.7% | +5.3% | +0.4% | -2.6% | +15.3% | +7.1% | +38.7% | -2.0% | +1.6% | +16.0% | +20.0% | +18.9% | -10.0% | +6.8% | -1.8% | -6.7% | +4.9% | +7.5% | -8.9% | +3.9% | +11.2% | +8.2% | +27.8% | -8.3% | +9.0% | +32.4% | -5.1% | +10.2% | +30.5% | +19.2% | -19.4% | +0.6% | – | |
| – | +6.0% | +2.3% | +3.6% | +19.8% | +15.7% | +36.3% | +1.9% | +4.6% | +4.1% | -10.1% | +6.3% | +11.2% | +7.3% | +6.5% | +4.8% | +14.3% | +8.8% | +17.3% | +8.9% | +0.1% | -1.9% | -0.8% | +7.8% | +3.6% | -3.9% | +4.0% | +9.4% | +5.6% | +10.2% | +16.5% | +3.7% | +6.6% | +27.5% | +3.2% | +11.6% | +10.9% | +6.2% | -6.9% | -2.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +4.6% | +3.0% | +8.1% | +10.6% | +3.2% | +3.5% | -5.6% | -23.4% | -24.9% | +2.1% | -2.0% | -2.1% | +1.4% | +0.0% | +1.4% | -1.4% | -25.0% | +183.3% | +1.6% | +166.2% | -60.3% | +71.4% | +93.3% | -79.0% | +59.0% | +6.3% | +4.4% | -2.5% | +1.0% | +2.0% | +1.5% | -2.2% | -5.2% | +2.4% | +0.5% | -12.0% | -2.9% | +2.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -102.1% | – | +1.5% | +4.2% | -101.7% | – | -1.3% | -3.4% | -97.7% | -8,950.0% | – | – | – | – | – | – | -168.4% | – | +150.0% | +7.2% | -153.4% | – | +71.4% | +93.3% | -79.0% | -1,439.3% | – | – | +611.9% | -93.4% | – | – | – | -88.8% | – | – | – | -88.7% | -37.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.